Advances in immune checkpoint inhibitor therapy for breast cancer: research progress and future directions

Breast cancer is the most prevalent malignancy among women worldwide. In recent years, immune checkpoint inhibitors (ICIs) have emerged as a promising therapeutic strategy across different molecular subtypes of breast cancer, demonstrating significant clinical potential. This review systematically s...

Full description

Saved in:
Bibliographic Details
Main Author: ZENG Cheng, WANG Yuanyi, WANG Jiani, MA Fei
Format: Article
Language:English
Published: Editorial Office of China Oncology 2025-02-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/1742381065222-729640604.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items